Featured

Trump: Iran asked me to be Supreme Leader, but I said no thanks

Trump’s “Iran asked me to be Supreme Leader” joke at an NRCC fundraiser uses a real, deadly leadership crisis in Iran to normalize assassination-as-policy and blur what’s confirmed about the war and succession.

Mar 26, 2026

Featured

‘Men need to be perp-walked’ after Epstein files release, Massie tells BBC

A GOP lawmaker says the Epstein document releases are still falling short—because redactions and withheld material may be blocking accountability and survivor-centered justice.

Mar 25, 2026

Buried.News

The stories buried under the noise

Primary focus

Trump fires Kristi Noem as Homeland Security Secretary

A Cabinet secretary was forced out amid contracting and oversight scrutiny, signaling that executive control—not transparent accountability—can dictate leadership of the agency driving mass detention and deportation.

Mar 5, 2026

Featured

The Trump gold coin is not normal : Consider This from NPR

A federal design panel OK’d a Trump portrait for a commemorative gold coin, but the key question is whether Treasury can legally bypass long-standing limits meant to keep living politicians off U.S. money.

Mar 23, 2026

Featured

White House Confronted Over Huge Bets Made Minutes Before Trump’s Big War Move

A $580 million burst of oil-futures selling minutes before Trump’s Iran “talks” post raises a basic public-interest question: did anyone trade on advance knowledge of a market-moving national security decision?

Mar 24, 2026

Norms Impact

Robert F. Kennedy Jr. to Launch National Autism Registry Using Americans’ Private Health Records

A federal health chief is building a national autism registry by consolidating private and government health data streams, normalizing population surveillance through research infrastructure.

Executive

⚖ Legal Exposure

Ethics Violation

Likely Unlawful

Potentially Criminal

Likely Criminal

The article indicates a large-scale aggregation and sharing of Americans’ health-related data for an autism registry and related studies, which creates significant investigative red flags for Privacy Act, HIPAA, and human-subjects research compliance. No facts describe a financial quid pro quo or personal enrichment, so the exposure is best characterized as potential unlawful/irregular procedure and privacy-compliance risk pending details on de-identification, authorizations/waivers, and safeguards.

Sources

https://people.com/rfk-jr-to-launch-autism-registry-using-private-health-records-11720156

Summary

NIH will provide HHS Secretary Robert F. Kennedy Jr. with data drawn from federal and commercial sources to support a new autism study and a national autism registry. The federal health research apparatus is being positioned to consolidate and distribute Americans’ health-adjacent data across agencies and private pipelines for targeted population tracking. The practical consequence is expanded government-enabled access to sensitive medical, claims, genomics, and wearable-device data, with outside researchers funded to use it.

Reality Check

Consolidating Americans’ medical, claims, genomics, and wearable data into a government-enabled registry architecture sets a precedent for surveillance-by-research that can outlive any single program and erode our expectation of medical privacy. On these facts alone, criminality is not established; the legal fault line will run through whether collection, linkage, and disclosure comply with HIPAA’s Privacy Rule (45 C.F.R. Parts 160 & 164), the Privacy Act of 1974 (5 U.S.C. § 552a), and applicable federal security standards for handling sensitive records. Even if technically authorized, routing broad “real-time health monitoring” capabilities to 10–20 outside groups via grants invites mission creep and turns public health research into an institutional pathway for normalized tracking of people’s lives.

Legal Summary

Legal Analysis

5 U.S.C. § 552a (Privacy Act of 1974) — Federal agency collection/use/disclosure of records

Article describes NIH providing HHS Secretary RFK Jr. data pulled from multiple federal and commercial databases and enabling access for 10–20 outside researcher groups; this raises Privacy Act concerns if identifiable records are used/disclosed without proper notice, routine use, consent, or statutory exception.
Combining datasets (VA/IHS genomics, insurer claims, pharmacy and lab records, wearables) creates heightened re-identification risk; legality hinges on whether data are de-identified and whether required system-of-records notices, safeguards, and permissible uses are followed (not established in the article).

HIPAA Privacy Rule (45 C.F.R. Parts 160 & 164) — Use/disclosure of protected health information

Data sources include pharmacy chains, labs, private insurers, and health-related device data; if covered entities/business associates disclose PHI for research, HIPAA generally requires authorization or an IRB/Privacy Board waiver and minimum-necessary controls.
The article does not specify whether disclosures are de-identified, authorized, or waived; the described “registry” and broad data aggregation create an investigative red flag for compliance and governance.

Federal human subjects research protections (Common Rule, 45 C.F.R. Part 46) — Research ethics/consent (where applicable)

Providing comprehensive patient data to outside groups with grant funding for autism studies may trigger requirements for IRB review and informed consent or documented waiver, depending on identifiability and research design.
The article does not provide process details; the main exposure is procedural/administrative noncompliance risk rather than a bribery-type transaction.

18 U.S.C. § 242 (Deprivation of rights under color of law) — High bar criminal civil-rights theory (generally unlikely here)

Even if privacy expectations are implicated, criminal exposure would typically require willful deprivation of a constitutional right; the article provides no facts indicating willful illegality or targeted discrimination.

Conclusion: The described conduct primarily presents procedural and compliance risk (privacy, research governance) from large-scale aggregation and sharing of sensitive health data, not a money-access-official-act corruption pattern based on the facts provided.

Media

Detail

On April 21, NIH Director Dr. Jay Bhattacharya announced that the National Institutes of Health will provide HHS Secretary Robert F. Kennedy Jr. with data pulled from multiple federal and commercial databases for autism research. Bhattacharya said the initiative includes launching a new registry to track Americans with autism and that between 10 and 20 outside research groups will receive access to the records along with grant funding to conduct the studies.

Bhattacharya stated that the combined data would include medical records from pharmacy chains, lab tests, genomics data from patients treated by the Department of Veterans Affairs and the Indian Health Service, claims data from private insurers, and information from smartwatches and fitness trackers, among other sources. He said the combined datasets would enable “comprehensive” patient data with broad U.S. population coverage and could support “real-time health monitoring.”

The announcement followed Kennedy’s April 16 press conference remarks about autism that drew criticism from autism advocates.

Norms Impact

VA hospitals remove politics and marital status from guidelines protecting patients from discrimination

By stripping anti-discrimination language from VA hospital bylaws and bypassing medical staff self-governance, political directives are being wired directly into veterans’ bedside access to care.

Executive

Jun 18, 2025

⚖ Legal Exposure

Ethics Violation

Likely Unlawful

Potentially Criminal

Likely Criminal

The article describes VA bylaw changes removing explicit non-discrimination language (politics, marital status, and in some contexts national origin/sexual orientation), imposed without medical staff consultation and framed as compliance with a presidential executive order. This creates a serious investigative red flag for politicized administration and potential civil/administrative exposure if the changes are used to deny care or drive discriminatory/retaliatory personnel decisions. The context does not indicate a transactional corruption scheme or specific completed criminal rights deprivation, so exposure is elevated but primarily investigatory at this stage.